ET
Elicio Therapeutics Inc.
🇺🇸XNAS.ELTXUnited StatesHealthcare
$1.77USDdown -0.22 (-11.06%)ClosedEnd of day12:15 AM
Price$1.77-0.22 (-11.06%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US28657F1030
- CUSIP
- 28657F103
Company
- Employees
- 33
- Headquarters
- Boston, United States
- Website
- https://elicio.com
- CEO
- Mr. Robert T. Connelly
Market
- Shares outstanding
- 26.3M
- Market cap
- $46.52M
Highlights
- Market cap
- $52.3M
- EPS LTM
- -$1.97
- P/E LTM
- -1.99
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$37.84M+30.71%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$37.71M-7.34%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.